To include your compound in the COVID-19 Resource Center, submit it here.

Merck & Co Inc. pharmaceuticals news

Merck provided an update to its ongoing restructuring in its 2Q11 earnings and said it remains on

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE